Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors

Cell Oncol (Dordr). 2011 Feb;34(1):55-67. doi: 10.1007/s13402-011-0012-1. Epub 2011 Feb 15.

Abstract

Background: Carcinoma-associated fibroblasts (CAF) are considered to contribute to tumor growth, invasion and metastasis. However, the cell type of origin remains unknown. Since human adipose tissue derived stem cells (hASCs) are locally adjacent to breast cancer cells and might directly interact with tumor cells, we investigated whether CAFs may originate from hASCs.

Methods: hASCs cultured under different conditions were quantified for the expression of alpha smooth muscle actin. ELISA was performed using the human TGFβ1, SDF-1α and CCL5 Quantikine Kit. The invasion potential of MDAMB231 cancer cells was evaluated using a Boyden chamber with filter inserts coated with Matrigel in 24-well dishes.

Results: We demonstrated that a significant percentage of hASCs differentiated into a CAF-like myofibroblastic phenotype (e.g. expression of alpha smooth muscle actin and tenascin-C) when exposed to conditioned medium from the human breast cancer lines MDAMB231 and MCF7. The conditioned medium from MDAMB231 and MCF7 contains significant amounts of transforming growth factor-beta 1 (TGFβ1) and the differentiation of hASCs towards CAFs is dependent on TGFβ1 signaling via Smad3 in hASCs. The induction of CAFs can be abolished using a neutralizing antibody to TGFβ1 as well as by pretreatment of the hASCs with SB431542, a TGFβ1 receptor kinase inhibitor. Additionally, we found that these hASC-derived CAF-like cells exhibit functional properties of CAFs, including the ability to promote tumor cell invasion in an in vitro invasion assay, as well as increased expression of stromal-cell derived factor 1 (SDF-1) and CCL5.

Conclusion: Our data suggest that hASCs are a source of CAFs which play an important role in the tumor invasion.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adipose Tissue / cytology*
  • Biomarkers / metabolism
  • Breast Neoplasms / pathology*
  • Cell Differentiation / drug effects*
  • Cell Line, Tumor
  • Chemokine CCL5 / metabolism
  • Chemokine CXCL12 / metabolism
  • Culture Media, Conditioned / pharmacology
  • Female
  • Flow Cytometry
  • Humans
  • Myofibroblasts / drug effects
  • Myofibroblasts / metabolism
  • Myofibroblasts / pathology*
  • Neoplasm Invasiveness
  • Phenotype
  • Stem Cells / cytology*
  • Stem Cells / drug effects*
  • Stem Cells / metabolism
  • Tenascin / metabolism
  • Transforming Growth Factor beta1 / pharmacology*
  • Tumor Microenvironment / drug effects

Substances

  • Biomarkers
  • CCL5 protein, human
  • Chemokine CCL5
  • Chemokine CXCL12
  • Culture Media, Conditioned
  • Tenascin
  • Transforming Growth Factor beta1